文献速递传染病防控与疫情报告免疫规划

瑞典2018至2019年蜱传脑炎病毒血清阳性率与蜱传脑炎疫苗接种覆盖率

Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019.
PubMed 文献 · Euro Surveill · 2024-01-01

2018至2019年,在瑞典九个地区采集2700份献血者血清,用可区分疫苗诱导与感染诱导抗体的血清学方法检测蜱传脑炎病毒(TBEV)血清阳性率。地区间总血清阳性率从9.7%(95%CI:6.6-13.6%)到64.0%(95%CI:58.3-69.4%)不等,疫苗接种比例从8.7%(95%CI:5.8-12.6)到57.0%(95%CI:51.2-62.6),感染比例从1.0%(95%CI:0.2-3.0)到7.0%(95%CI:4.5-10.7)。估计分别有超过160,000人和1,600,000人感染TBEV和接种TBE疫苗,平均表现指数为3.1%。

要点

  • 地区间TBEV总血清阳性率从9.7%到64.0%不等。
  • 疫苗接种比例从8.7%到57.0%,感染比例从1.0%到7.0%。
  • 平均表现指数为3.1%,作者认为大部分TBEV感染未被诊断。

核心结论

  • 低发病率与高发病率TBE地区之间,总TBEV血清阳性率以及分开的疫苗接种和感染比例均存在差异。
  • 估计的发病率和表现指数表明,大部分TBEV感染未被诊断。

研究设计与样本

  • 2018年和2019年,在瑞典九个地区采集2700份献血者血清样本,使用可区分疫苗诱导抗体与感染诱导抗体的血清学方法进行分析。
  • 九个地区的选择旨在反映报告TBE发病率的差异。

主要发现

  • 地区间总血清阳性率从9.7%(95%CI:6.6-13.6%)到64.0%(95%CI:58.3-69.4%)不等。
  • 疫苗接种比例从8.7%(95%CI:5.8-12.6)到57.0%(95%CI:51.2-62.6),感染比例从1.0%(95%CI:0.2-3.0)到7.0%(95%CI:4.5-10.7)。
  • 估计分别有超过160,000人和1,600,000人感染TBEV和接种TBE疫苗。
  • 平均表现指数为3.1%。

关键数值与推荐

  • 总血清阳性率范围:9.7%(95%CI:6.6-13.6%)至64.0%(95%CI:58.3-69.4%)。
  • 疫苗接种比例范围:8.7%(95%CI:5.8-12.6)至57.0%(95%CI:51.2-62.6)。
  • 感染比例范围:1.0%(95%CI:0.2-3.0)至7.0%(95%CI:4.5-10.7)。
  • 平均表现指数:3.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundIn Sweden, information on seroprevalence of tick-borne encephalitis virus (TBEV) in the population, including vaccination coverage and infection, is scattered. This is largely due to the absence of a national tick-borne encephalitis (TBE) vaccination registry, scarcity of previous serological studies and use of serological methods not distinguishing between antibodies induced by vaccination and infection. Furthermore, the number of notified TBE cases in Sweden has continued to increase in recent years despite increased vaccination.AimThe aim was to estimate the TBEV seroprevalence in Sweden.MethodsIn 2018 and 2019, 2,700 serum samples from blood donors in nine Swedish regions were analysed using a serological method that can distinguish antibodies induced by vaccination from antibodies elicited by infection. The regions were chosen to reflect differences in notified TBE incidence.ResultsThe overall seroprevalence varied from 9.7% (95% confidence interval (CI): 6.6-13.6%) to 64.0% (95% CI: 58.3-69.4%) between regions. The proportion of vaccinated individuals ranged from 8.7% (95% CI: 5.8-12.6) to 57.0% (95% CI: 51.2-62.6) and of infected from 1.0% (95% CI: 0.2-3.0) to 7.0% (95% CI: 4.5-10.7). Thus, more than 160,000 and 1,600,000 individuals could have been infected by TBEV and vaccinated against TBE, respectively. The mean manifestation index was 3.1%.ConclusionA difference was observed between low- and high-incidence TBE regions, on the overall TBEV seroprevalence and when separated into vaccinated and infected individuals. The estimated incidence and manifestation index argue that a large proportion of TBEV infections are not diagnosed.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Albinsson B, Hoffman T, Kolstad L, et al. Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019. Euro Surveill. 2024. PMID: 38214080. doi:10.2807/1560-7917.ES.2024.29.2.2300221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。